They have not been evaluated by the U.S
If the drug proves successful, OKAVA intends to launch a larger clinical trial next year and apply for approval from the US Food and Drug Administration (FDA)
Watch-out: Mixed public reputation with a 3.7 Trustpilot rating (3,200+ reviews) and a B from the BBB
Side Effects and Safety Information The following safety overview draws from information published on the official Joi + Blokes website alongside general FDA context on GLP-1 receptor agonists
Cardiovascular Considerations PT-141 can cause transient increases in blood pressure and heart rate, with mean increases of 3-10 mmHg systolic and 2-5 mmHg diastolic pressure observed in clinical trials
Semaglutide can be an effective tool in reducing several COVID-19 risk factors, such as obesity, high blood sugar, and cardiovascular issues